Bao Shao - Golden Meditech CEO - Chinese Herbal Medicine Operation
CEO
Mr. Shao Bao Ping is Chief Executive Officer Chinese Herbal Medicine Operation of Golden Meditech Holdings Ltd. He joined the Group in August 2005. Mr. Shao obtained masters degree from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences and has work experience in the fields of pharmacology and herbal medicine. Mr. Shao has held key position in wellknown enterprises in the PRC and has corporate management experience. since 2011.
| Age | 47 |
| Tenure | 13 years |
| Phone | 852 3605 8180 |
| Web | http://www.goldenmeditech.com |
Golden Meditech Management Efficiency
The company has return on total asset (ROA) of (2.21) % which means that it has lost $2.21 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (6.87) %, meaning that it generated substantial loss on money invested by shareholders. Golden Meditech's management efficiency ratios could be used to measure how well Golden Meditech manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 115.29 M in total debt with debt to equity ratio (D/E) of 0.23, which may suggest the company is not taking enough advantage from borrowing. Golden Meditech Holdings has a current ratio of 1.47, which is within standard range for the sector. Debt can assist Golden Meditech until it has trouble settling it off, either with new capital or with free cash flow. So, Golden Meditech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Golden Meditech Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Golden to invest in growth at high rates of return. When we think about Golden Meditech's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 6 records | CEO Age | ||
| Gaofei Wang | Weibo Corp | 45 | |
| Michael Baur | ScanSource | 67 | |
| Donald Thoma | Iridium Communications | 62 | |
| Robert Bruggeworth | Qorvo Inc | 63 | |
| Matthew Desch | Iridium Communications | 66 | |
| James Dolan | Sphere Entertainment Co | 69 | |
Management Performance
| Return On Equity | -6.87 | |||
| Return On Asset | -2.21 |
Golden Meditech Holdings Leadership Team
Elected by the shareholders, the Golden Meditech's board of directors comprises two types of representatives: Golden Meditech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Golden. The board's role is to monitor Golden Meditech's management team and ensure that shareholders' interests are well served. Golden Meditech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Golden Meditech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gang Cao, Independent Non-Executive Director | ||
| Yuen Kam, Founder, Chairman, CEO, Compliance Officer and Chairman of Executive Committee | ||
| Tsz Poon, Independent Non-Executive Director | ||
| Kwok Yu, COO and Executive Director | ||
| Qiao Gu, Independent Non-Executive Director | ||
| Wei Ding, CEO of GM Medicare (China) Co., Ltd | ||
| Jin Zhang, CEO - Hospital Management Operation | ||
| Wen Feng, Non-Executive Independent Director | ||
| Bao Shao, CEO - Chinese Herbal Medicine Operation | ||
| Daniel Foa, Independent Non-Executive Director | ||
| Yue Gao, Non-Executive Director | ||
| Xuan Duan, President - Beijing Dao Pei Hospital, MD - Shanghai Dao Pei Hospital, EVC - China Private Hospital Development League | ||
| Guang Gao, Deputy General Manager - Medical Devices Operation | ||
| Ting Zheng, Non-Executive Director | ||
| Kim Leong, CEO, Executive Director | ||
| Jian Jing, Vice President and Chief Representative, Shanghai; CEO of Golden Meditech (Shanghai) Company Limited | ||
| Kam Kong, COO, Executive Director, Company Secretary | ||
| Cheuk Lam, Secretary |
Golden Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Golden Meditech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -6.87 | |||
| Return On Asset | -2.21 | |||
| Profit Margin | (85.10) % | |||
| Current Valuation | 291.69 M | |||
| Shares Outstanding | 2.92 B | |||
| Shares Owned By Insiders | 72.58 % | |||
| Shares Owned By Institutions | 11.04 % | |||
| Price To Earning | 0.73 X | |||
| Price To Book | 0.48 X | |||
| Price To Sales | 7.85 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in Golden Pink Sheet
If you are still planning to invest in Golden Meditech Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Golden Meditech's history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Commodity Directory Find actively traded commodities issued by global exchanges |